Rocket Pharmaceuticals Inc (RCKT)
22.80
-0.03
(-0.13%)
USD |
NASDAQ |
May 21, 10:37
Rocket Pharmaceuticals Cash from Financing (Quarterly): 1.184M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.184M |
December 31, 2023 | 0.391M |
September 30, 2023 | 189.48M |
June 30, 2023 | 0.182M |
March 31, 2023 | 18.34M |
December 31, 2022 | 108.44M |
September 30, 2022 | 29.53M |
June 30, 2022 | 17.25M |
March 31, 2022 | 0.076M |
December 31, 2021 | 1.136M |
September 30, 2021 | 26.64M |
June 30, 2021 | 1.115M |
March 31, 2021 | 8.792M |
December 31, 2020 | 282.44M |
September 30, 2020 | 0.512M |
June 30, 2020 | 0.151M |
March 31, 2020 | -0.117M |
December 31, 2019 | 92.41M |
September 30, 2019 | 0.031M |
June 30, 2019 | 85.35M |
March 31, 2019 | 0.00 |
Date | Value |
---|---|
December 31, 2018 | 74.84M |
September 30, 2018 | 0.149M |
June 30, 2018 | 0.00 |
March 31, 2018 | 78.52M |
December 31, 2017 | -25.39M |
September 30, 2017 | -0.039M |
June 30, 2017 | 3.896M |
March 31, 2017 | 21.55M |
December 31, 2016 | 0.213M |
September 30, 2016 | 48.69M |
June 30, 2016 | 4.182M |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.073M |
September 30, 2015 | 73.97M |
June 30, 2015 | -0.04M |
March 31, 2015 | 51.51M |
December 31, 2014 | 1.255M |
September 30, 2014 | -0.687M |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.117M
Minimum
Mar 2020
282.44M
Maximum
Dec 2020
43.17M
Average
4.988M
Median
Cash from Financing (Quarterly) Benchmarks
Ligand Pharmaceuticals Inc | 12.18M |
ADMA Biologics Inc | -1.447M |
ACADIA Pharmaceuticals Inc | 1.043M |
Alnylam Pharmaceuticals Inc | 28.91M |
Geron Corp | 147.80M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -56.86M |
Cash from Investing (Quarterly) | 35.03M |
Free Cash Flow | -209.70M |
Free Cash Flow Per Share (Quarterly) | -0.6295 |
Free Cash Flow Yield | -10.51% |